BioSpace News Archive

FDA

Eli Lilly’s Cyramza Approved for HCC Patients, Boxed Warning Label Removed by FDA

The drug was approved as a second-line treatment for HCC patients who have an alpha-fetoprotein biomarker.

May 13, 2019
·
2 min read
·
Alex Keown
Medidata NEXT London 2019: Blending the Best of Clinical Development, AI-Enabled Platform Demonstrations and Regulatory Compliance for Leaders in Life Sciences

Attend NEXT London 2019 to explore how the European Life Science landscape can embrace digital transformation to stay ahead of regulatory and market developments

May 13, 2019
·
4 min read
Policy

Sandoz, Teva Vow to Fight Price-Fixing Allegations

The two generic drugmakers, along with many others, have been accused of conspiring to inflate the price of more than 100 generic drugs.

May 13, 2019
·
2 min read
·
Alex Keown
Deals

Bankruptcy Looms as Insys Scrapes Together Cash for Legal Disputes

Insys owes more than $240 million in legal-related fees but the company only has about $87 million in available cash.

May 13, 2019
·
2 min read
·
Alex Keown
Drug Development

Polyphor Shares Plunge After it Halts Enrollment in Two Pneumonia Trials Due to Safety Concerns

The company said that its lead product was creating greater-than anticipated kidney injuries in trial patients.

May 13, 2019
·
2 min read
·
Alex Keown
Drug Development

Injectable Peptide Might Help Spinal Cord Injury Patients Walk Again

A systemically injectable peptide, which may make it possible to restore lost functions in spinal cord injury patients, is moving toward clinical trials in early 2020. It has seen success in animal models.

May 13, 2019
·
2 min read
·
Gaius J. Augustus, PhD, Multimedia Science Communicator
Pharm Country

Carestream Releases ImageView Software for DRX-Revolution Mobile X-ray System

New software offers advanced features, enhanced workflow and improved security

May 13, 2019
·
2 min read
12th BioVaria brings academia and industry together

BioVaria Start-up Awards go to ISD Immunotech and Mindpax.me

May 13, 2019
·
5 min read
Business

Retrophin Appoints Sandra E. Poole to Board of Directors

Ms. Poole brings more than 25 years of biopharmaceutical product development and manufacturing experience to Retrophin

May 13, 2019
·
5 min read
Business

ElevateBio Launches with $150 Million Aimed at Growing Cell and Gene Therapy Companies

The new incubator, located in Cambridge, Mass., launched with a $150 million Series A financing round.

May 13, 2019
·
2 min read
·
Alex Keown